| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.05 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.07 |